Inactive Instrument

Nu-Med Plus Inc Stock OTC Bulletin Board

Equities

US67021R1041

Medical Equipment, Supplies & Distribution

End-of-day quote OTC Bulletin Board
- USD - Intraday chart for Nu-Med Plus Inc
Sales 2022 - Sales 2023 - Capitalization 3.38M
Net income 2022 - Net income 2023 - EV / Sales 2022 -
Net Debt 2022 26.8K Net Debt 2023 93.19K EV / Sales 2023 -
P/E ratio 2022
-10.1 x
P/E ratio 2023
-26.3 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 54.96%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 59 22-09-11
Director of Finance/CFO 78 15-07-31
Members of the board TitleAgeSince
Director of Finance/CFO 78 15-07-31
Chief Executive Officer 75 -
Chief Executive Officer 59 22-09-11
More insiders
Nu-Med Plus, Inc. is a medical device company, which is principally engaged in the designing, development, enhancement and commercialization of later-stage medical devices. The Company is focused on the creation of a nitric oxide generating formulation, a hospital bedside nitric oxide delivery system, a clinical unit for use in medical clinics and rehabilitation centers and a mobile rechargeable device to deliver nitric oxide gas to offer solutions to hospitals, health systems and the medical community throughout the world. Hospital NO Unit delivers a continuous intra-breath concentration of therapeutic NO to patients who are on a ventilator in a hospital setting. Clinical Delivery System is a simplified version of the hospital unit. Portable Delivery System delivers high purity NO to the patient at prescribed intervals for 24 hours per day at controlled doses by means of a nasal cannula or a face mask. Reagent Delivery provides a range of concentrations and flow rates of NO.
More about the company